NVK-032
N/A
Report date: 2024/12/12 16:37:30
Base Information
Drug NameNVK-032
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[1] N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNevakar
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A